Structure Therapeutics Inc. — Director's Dealing 2023

Feb 3, 2023

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Structure Therapeutics Inc. (GPCR)
CIK: 0001888886
Period of Report: 2023-02-02

Reporting Person: WELCH DANIEL G (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series B Preferred Shares	$		Ordinary Shares (123508)		Indirect
Stock option (right to buy)	$2.60	2032-01-19	Ordinary Shares (1179122)		Direct

Footnotes

F1: All outstanding Preferred Shares will automatically convert into Ordinary Shares immediately upon the closing of Issuer's initial public offering, for no additional consideration at a rate of one Ordinary Share for each one Preferred Share, based on the conversion price currently in effect. The Preferred Shares have no expiration date.

F2: 1/3rd of the shares shall vest one year after January 5, 2022 (the "Vesting Commencement Date"); the balance of the shares vest in a series of 24 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date.